Clinical Trial Results: Positive data boosts investor confidence, driving up the stock price. Conversely, negative results or trial failures lead to price declines.

Regulatory Approvals: FDA approval of ALDX.US's drugs or therapies significantly increases the company's market potential, resulting in stock price appreciation. Denial or delays have the opposite effect.

Market Sentiment: General investor mood towards the biotechnology sector or smaller cap stocks can impact ALDX.US. Bullish sentiment often lifts the price, while bearish sentiment can depress it.

Financial Performance: Strong revenue growth, profitability, and healthy cash flow positively influence investor perception and stock valuation. Conversely, losses or weak financials can negatively affect the stock price.

Competition: The emergence of competing drugs or therapies from other companies can reduce ALDX.US's market share and potential revenue, impacting its stock price negatively.

Partnerships and Collaborations: Strategic alliances or collaborations with larger pharmaceutical companies can validate ALDX.US's technology and increase its market reach, leading to stock price gains.

Macroeconomic Factors: Economic conditions like interest rates, inflation, and overall economic growth can indirectly impact the biotechnology sector and ALDX.US's stock.

Company News: Press releases regarding new product developments, research updates, or management changes can influence investor sentiment and stock price movements.